Rocco Venezia

CAO at Intercept Pharmaceuticals

Rocco Venezia serves as the Chief Accounting Officer and brings more than 20 years of relevant finance and accounting experience to the role. Prior to becoming Chief Accounting Officer in March 2021, Mr. Venezia served as Intercept’s Corporate Controller since 2016, where he led the expansion of the company’s finance and accounting department during its transition from development-stage to a fully integrated commercial organization. Before he joined Intercept, Mr. Venezia was the Assistant Corporate Controller at IKARIA, Inc., now part of Mallinckrodt Pharmaceuticals, from 2013 to 2016, where he led the accounting and finance team through operational and system transformations. From 2000 to 2013, Mr. Venezia held roles of increasing responsibility at KPMG LLP and Arthur Andersen, where he led multinational audits, transactions, and due diligence engagements across several industries. Mr. Venezia also spent three years at KPMG LLP’s Department of Professional Practice where he supported engagement teams on complex technical accounting, compliance matters, and audit methodology. Mr. Venezia holds a bachelor’s degree in accounting from Kean University and is a certified public accountant in New Jersey and New York.

Links

Timeline

  • CAO

    Current role

  • Chief Accounting Officer and Acting CFO

    March 26, 2021